- Global perspectives on rheumatology training: insights from the EULAR 2025 EMEUNET Presents session
2026EULAR Rheumatology OpenJournalOpen accessFirst authorCorresponding0 citations10.1016/j.ero.2026.02.005
- Interventions aimed at advancing gender equity in rheumatology: Insights from the Coalition for Health and Gender Equity (CHANGE) survey
2026Autoimmunity ReviewsJournalOpen accessFirst authorCorresponding0 citations10.1016/j.autrev.2026.104172
- Social media landscape: a cross-sectional survey of health professionals
2025Rheumatology InternationalJournalOpen accessCorresponding1 citations10.1007/s00296-025-06000-4
- Reduced Health‐Related Quality of Life in Patients With Systemic Sclerosis: A Cross‐Sectional Analysis of PROMIS Global Health Data From the International COVAD ‐2 e‐Survey
2025International Journal of Rheumatic DiseasesJournal0 citations10.1111/1756-185x.70101
- Global social media use among rheumatology professionals: the EULAR SoMeR Study Group survey
2025RMD OpenJournalOpen accessFirst author0 citations10.1136/rmdopen-2025-006179
- Characteristics of emerging new autoimmune diseases after COVID ‐19 vaccination: A sub‐study by the COVAD group
2024International Journal of Rheumatic DiseasesJournalOpen accessCorresponding8 citations10.1111/1756-185x.15178
- The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset
2024Lara D. VeekenJournalOpen accessCorresponding6 citations10.1093/rheumatology/keae520
- Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology
2024Rheumatology Advances in PracticeJournalOpen accessCorresponding4 citations10.1093/rap/rkae021
- Gender equity in global rheumatology awards
2024Annals of the Rheumatic DiseasesJournalSenior authorCorresponding4 citations10.1136/ard-2024-225670
- Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
2024Rheumatology Advances in PracticeJournalOpen accessCorresponding6 citations10.1093/rap/rkae028
- Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
2024Rheumatology InternationalJournalOpen accessCorresponding4 citations10.1007/s00296-024-05562-z
- Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges
2024International Journal of Rheumatic DiseasesJournalOpen accessCorresponding3 citations10.1111/1756-185x.15161
- Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
2024Rheumatology Advances in PracticeJournalOpen access1 citations10.1093/rap/rkae154
- Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
2024Lara D. VeekenJournalOpen accessCorresponding1 citations10.1093/rheumatology/keae128
- COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey
2024Rheumatology InternationalJournalOpen access1 citations10.1007/s00296-024-05742-x
- Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
2023The Lancet RheumatologyJournalOpen access35 citations10.1016/s2665-9913(23)00215-1
- Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
2023Lara D. VeekenJournalOpen accessCorresponding10 citations10.1093/rheumatology/kead180
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
2023Lara D. VeekenJournalOpen accessCorresponding8 citations10.1093/rheumatology/kead149
- Flares of autoimmune rheumatic disease following COVID ‐19 infection: Observations from the COVAD study
2023International Journal of Rheumatic DiseasesJournalOpen accessSenior author7 citations10.1111/1756-185x.14961
- COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus
2023Journal of Clinical MedicineJournalOpen access4 citations10.3390/jcm12247542
- COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
2023Lara D. VeekenJournalOpen accessCorresponding4 citations10.1093/rheumatology/kead382
- Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort
2023Rheumatology InternationalJournalOpen access3 citations10.1007/s00296-023-05441-z
- POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY
2023Annals of the Rheumatic DiseasesJournalOpen accessSenior author1 citations10.1136/annrheumdis-2023-eular.4241
- LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study
2023PublicationOpen access0 citations10.1136/lupus-2023-kcr.19
- COVAD survey 2 long-term outcomes: unmet need and protocol
2022Rheumatology InternationalJournalOpen accessCorresponding44 citations10.1007/s00296-022-05157-6